WallStreetZenWallStreetZen

NASDAQ: CGEN
Compugen Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CGEN stock forecasts and price targets.

Forecast return on equity

Is CGEN forecast to generate an efficient return?

Company
-75.94%
Industry
257.22%
Market
146.17%
CGEN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CGEN forecast to generate an efficient return on assets?

Company
-35.82%
Industry
109.18%
CGEN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CGEN earnings per share forecast

What is CGEN's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.34
Avg 2 year Forecast
-$0.26
Avg 3 year Forecast
-$0.21

CGEN revenue forecast

What is CGEN's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$6.6M-70.28%
Avg 2 year Forecast
$20.3M-8.44%
Avg 3 year Forecast
$31.3M+41.46%
CGEN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CGEN revenue growth forecast

How is CGEN forecast to perform vs Biotechnology companies and vs the US market?

Company
12.78%
Industry
108.19%
Market
25.27%
CGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CGEN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CGEN$1.65N/AN/A
FATE$1.34$3.88+189.18%Buy
MIST$1.84$4.50+144.57%Strong Buy
ALEC$1.55$4.50+190.32%Strong Buy
ELTX$9.40$13.00+38.30%Buy
View Top Biotech Stocks

Compugen Stock Forecast FAQ

What is CGEN's earnings growth forecast for 2025-2027?

(NASDAQ: CGEN) Compugen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 26.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.98%.

Compugen's earnings in 2025 is -$19,364,000.On average, 6 Wall Street analysts forecast CGEN's earnings for 2025 to be -$32,120,042, with the lowest CGEN earnings forecast at -$34,832,567, and the highest CGEN earnings forecast at -$29,463,637. On average, 6 Wall Street analysts forecast CGEN's earnings for 2026 to be -$24,487,556, with the lowest CGEN earnings forecast at -$40,332,446, and the highest CGEN earnings forecast at -$2,946,364.

In 2027, CGEN is forecast to generate -$19,399,233 in earnings, with the lowest earnings forecast at -$32,999,274 and the highest earnings forecast at $5,892,727.

If you're new to stock investing, here's how to buy Compugen stock.

What is CGEN's revenue growth forecast for 2025-2027?

(NASDAQ: CGEN) Compugen's forecast annual revenue growth rate of 12.78% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 108.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.27%.

Compugen's revenue in 2025 is $22,144,000.On average, 6 Wall Street analysts forecast CGEN's revenue for 2025 to be $615,556,184, with the lowest CGEN revenue forecast at $320,826,275, and the highest CGEN revenue forecast at $820,772,758. On average, 6 Wall Street analysts forecast CGEN's revenue for 2026 to be $1,896,429,363, with the lowest CGEN revenue forecast at $0, and the highest CGEN revenue forecast at $4,874,501,595.

In 2027, CGEN is forecast to generate $2,929,995,058 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $6,593,213,780.

What is CGEN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CGEN) forecast ROA is -35.82%, which is lower than the forecast US Biotechnology industry average of 109.18%.

What is CGEN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CGEN) Compugen's current Earnings Per Share (EPS) is -$0.22. On average, analysts forecast that CGEN's EPS will be -$0.34 for 2025, with the lowest EPS forecast at -$0.37, and the highest EPS forecast at -$0.32. On average, analysts forecast that CGEN's EPS will be -$0.26 for 2026, with the lowest EPS forecast at -$0.43, and the highest EPS forecast at -$0.03. In 2027, CGEN's EPS is forecast to hit -$0.21 (min: -$0.35, max: $0.06).

What is CGEN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CGEN) forecast ROE is -75.94%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.